A. Epstein

发表

Infectious keratitis with corneal perforation associated with corneal hydrops and contact lens wear in keratoconus.

E. Donnenfeld, A. Schrier, H. Perry, 1996, The British journal of ophthalmology.

23rd Bethesda conference: access to cardiovascular care. Task Force 2: Human and systems resources for cardiovascular care.

R. Cooper, L. Iezzoni, R. Gunnar, 1992, Journal of the American College of Cardiology.

A novel antibiofilm technology for contact lens solutions.

E. Donnenfeld, H. Perry, A. Epstein, 1995, Ophthalmology.

The impact of overnight wear on the risk of contact lens-associated ulcerative keratitis.

A. Epstein, J. Freedman, 1994, Archives of ophthalmology.

Contact Lens Care Products Effect on Corneal Sensitivity and Patient Comfort

A. Epstein, 2006, Eye & contact lens.

Glued-on, rigid gas-permeable contact lens for severe radiation-induced keratitis.

E. Donnenfeld, H. Perry, H. Ingraham, 1992, American journal of ophthalmology-glaucoma.

Recent Fusarium outbreak.

A. Epstein, 2007, Eye & contact lens.

In the aftermath of the Fusarium keratitis outbreak: What have we learned?

Arthur B Epstein, A. Epstein, 2007, Clinical ophthalmology.

Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model

B. Lanier, D. Granet, I. Finegold, 2004, Current medical research and opinion.

Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge model.

A. Epstein, J. Stoppel, G. Berdy, 2002, Clinical therapeutics.

Keratitis Associated with Hydrogen Peroxide Disinfection in Soft Contact Lens Wearers

A. Epstein, J. Freedman, 1990 .

Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin

C. Brimer, A. Epstein, D. Stroman, 2017, Clinical ophthalmology.

The case for continuous wear.

E. Donnenfeld, H. Perry, A. Epstein, 2003, Eye & contact lens.

Retained Aspergillus-contaminated contact lens inducing conjunctival mass and keratoconjunctivitis in an immunocompetent patient.

E. Donnenfeld, H. Perry, A. Epstein, 1998, The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc.

Efficacy of Once-Daily Olopatadine 0.2% Ophthalmic Solution Compared to Twice-Daily Olopatadine 0.1% Ophthalmic Solution for the Treatment of Ocular Itching Induced by Conjunctival Allergen Challenge

M. Abelson, D. Spangler, A. Epstein, 2007, Current eye research.

Management of allergic conjunctivitis: an evaluation of the perceived comfort and therapeutic efficacy of olopatadine 0.2% and azelastine 0.05% from two prospective studies

W. Carr, A. Epstein, A. Kaufman, 2009, Clinical ophthalmology.

Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.

D. Granet, I. Finegold, A. Epstein, 2006, Clinical therapeutics.

Evaluation of Comfort Using Olopatadine Hydrochloride 0.1% Ophthalmic Solution in the Treatment of Allergic Conjunctivitis in Contact Lens Wearers Compared to Placebo Using the Conjunctival Allergen-Challenge Model

M. Irkec, W. Berger, A. Epstein, 2003, Eye & contact lens.

Ulcerative keratitis among users of contact lenses.

E. C. Poggio, R. Glynn, J. Seddon, 1990, The New England journal of medicine.

reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin

C. Brimer, A. Epstein, D. Stroman, 2017 .